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Abstract 
Since the recent discovery of selenocysteine as the 21st 
amino acid in protein, the field of selenium biology has 
rapidly expanded. Twelve mammalian selenoproteins 
have been characterized to date and each contains sele- 
nocysteine that is incorporated in response to specific 
UGA code words. These selenoproteins have different 
cellular functions, but in those selenoproteins for which 
the function is known, selenocysteine is located at the 
active center. The presence of selenocysteine at critical 
sites in naturally occurring selenoproteins provides an 
explanation for the important role of selenium in human 
health and development. This review describes known 
mammalian selenoproteins and discusses recent devel- 
opments and future directions in the selenium field. 
Selenium is an essential element for many forms of life. 
It is a component of naturally occurring selenium-con- 
taining proteins and transfer RNAs. In mammals, seleni- 
um is covalently bound in all selenoproteins described to 
date as the amino acid selenocysteine (Sec) [48]. In bacte- 
rial proteins, selenium also occurs as Sec [49], but in addi- 
tion this element is present in some selenoproteins a a 
dissociable, catalytically essential cofactor [26, 27, 36, 
37]. Selenium-containing tRNAs have been detected in 
mammals [19] and bacteria [20], but only bacterial sele- 
no-tRNAs have been characterized [98]. The present 
review will discuss known selenoproteins in mammals 
and future developments in the selenium field. Additional 
information on the biology of selenium may be found in 
other ecent reviews [14, 46, 48, 51, 62, 63, 66, 86]. 
The Past: The 21st Amino Acid in Protein 
The discovery that the code word UGA has a dual 
function in the 'almost' universal genetic ode [46] marks 
the first addition to the code [64] since it was deciphered 
[57, 75] and reported to be universal in the mid 1960s 
[70]. UGA serves as both a codon for termination of pro- 
tein synthesis and as a codon for Sec. In this sense, UGA 
is analogous to AUG, which functions as both a codon for 
initiation of protein synthesis and a codon for methionine 
at internal positions of proteins. The role of UGA as a 
codon for Sec has been known for about 10 years [64]. 
However, the fact that Sec is the 21st naturally occurring 
amino acid in protein is completely accepted as Sec has its 
own tRNA, code word, translation factors and other com- 
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ponents involved in the protein translation machinery 
[14, 48]. The presence ofa Sec insertion sequence (SECIS) 
element downstream of the UGA codon that codes for 
this amino acid is necessary for its recognition as a signal 
for Sec insertion [66]. Mammalian SECIS elements are 
stem-loop structures located in the 3'-untranslated region 
of selenoprotein mRNAs [66], while the corresponding 
stem-loop structures in bacterial selenoproteins are im- 
mediately downstream ofthe UGA Sec codon [14]. 
An interesting feature of Sec biosynthesis  that this 
amino acid is synthesized on its tRNA. There are many 
common steps in Sec biosynthesis in mammalian and 
bacterial systems, but the biosynthesis ofthis amino acid 
has only been completely established in prokaryotes [ 14]. 
Sec tRNA is first aminoacylated with serine, the serine 
moiety is in turn modified to an aminoacrylyl interme- 
diate on tRNA in bacterial systems by Sec synthase and 
then the intermediate s rves as the acceptor for activated 
selenium. The selenium donor is selenophosphate which 
is synthesized by selenophosphate synthetase [86]. Many 
of these steps are apparently very similar in mammals 
with the exception that the intermediate in Sec biosynthe- 
sis has not been identified and may actually be phospho- 
seryl-tRNA [47, 48]. In any case, this unique pathway is 
highly specific for selenium as sulfur shares many chemi- 
cal and physical properties with selenium, but sulfur can- 
not replace selenium in Sec biosynthesis. On the other 
hand, selenium can readily substitute for sulfur in sulfur 
pathways and be incorporated nonspecifically into pro- 
teins in the form of selenomethionine (r placing methio- 
nine), Sec (replacing cysteine) and selenium analogs of 
sulfur cofactors [reviewed in 48]. 
The Present: 
Selenoproteins, an Even Dozen Thus Far 
Twelve mammalian selenoproteins have been de- 
scribed to date which are shown in table 1. They represent 
various protein families. Sec is present at the active cen- 
ters of the characterized selenoenzymes which are the glu- 
tathione peroxidases, the iodothyronine deiodinases, 
thioredoxin reductase and selenophosphate synthetase. 
Although Sec occurs infrequently in protein compared to 
other amino acids, its presence at a critical site in these 
enzymes suggests hat selenium is important for a variety 
of biological processes and for human health [63]. 
A common feature among mammalian selenoproteins 
is that they appear to regulate and/or be regulated by intra- 
and/or extracellular redox processes. Nature may have tak- 
en advantage of utilizing Sec at critical sites in certain 
enzymes due to the unique redox properties of selenium 
[ 16]. Although Sec is structurally similar to cysteine, sele- 
nium is a better nucleophile than sulfur and selenocys- 
teines are ionized at physiological pH, while cysteines typ- 
ically are protonated [48, 86]. The biological function of 
several selenoproteins, including selenoprotein P, seleno- 
protein W and the 15-kd selenoprotein, remains un- 
known. These proteins, however, contain putative Sec 
redox-active centers and it is therefore tempting to specu- 
late that these centers erve a redox-dependent function. 
The Glutathione Peroxidase Family 
The glutathione peroxidase selenoenzyme family con- 
tains four members, GPX1, GPX2, GPX3 and GPX4. 
GPX1 is also called classical or cytosolic glutathione per- 
oxidase, GPX2, gastrointestinal glutathione peroxidase, 
GPX3, plasma glutathione peroxidase, and GPX4, phos- 
pholipid hydroperoxide glutathione peroxidase. GPX1, 
GPX2, GPX3 and GPX4 have also been abbreviated as 
cGPX, GPX-GI, pGPX and PHGPX, respectively. Glu- 
tathione peroxidases are homologous enzymes, which 
share several common features uch as they catalyze glu- 
tathione-dependent degradation of hydroperoxides and 
utilize Sec as a critical component of the enzyme active 
center. However, each member of this class of selenoen- 
zymes has several distinct characteristics and our current 
knowledge of each is summarized below. Additional in- 
formation on the glutathione peroxidase family of en- 
zymes may be found in the following reviews [2, 22, 48, 
88, 93, 94]. 
(1) Glutathione Peroxidase I (GPX1 or cGPX). GPX1 
is one of the most horoughly studied and best-character- 
ized selenoproteins. It catalyzes glutathione-dependent 
reduction of hydrogen peroxide and various organic hy- 
droperoxides. The enzyme is a homotetramer of - 22 kd 
subunits and it is located in the cytosol. The genes for 
mouse GPXI and Escherichia coli formate dehydroge- 
nase H were the first selenoprotein genes to be s quenced, 
which revealed that Sec is encoded by TGA [18, 103]. 
Bovine erythrocyte GPX1 has been crystallized and its 
three-dimensional structure determined [29]. Although 
GPX 1 is considered, together with catalase and superox- 
ide dismutase, as a major antioxidant enzyme, its role as 
an essential ntioxidant has been questioned. Indeed, dra- 
matic losses in GPX1 activity and expression level occur 
in selenium-deficient a imals [89] without an apparent 
effect on cellular metabolism. Such observations led in- 
vestigators topropose that GPX 1 may serve as a selenium 
storage or selenium buffer protein [88]. In addition, when 
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Table 1. Mammalian selenocysteine-containing proteins 
1 Glutathione peroxidase 1 Glutathione-dependent Ubiquitous h 3q 11-13.1 
(GPXt or cGPX) hydroperoxide removal and/or 3p21.3 
m chr. 9 
2 Glutathione peroxidase 2 Glutathione-dependent Gastrointestinal tract h 14q24.1 
(GPX2 or GPX-GI) hydroperoxide removal m chr. 12 
3 Glutathione peroxidase 3 Antioxidant Plasma h chr. 5 
(GPX3 or pGPX) (hydroperoxide removal) m chr. 11 
4 Phospholipid hydroperoxide Phospholipid hydroperoxide Ubiquitous h 19pl 3.3 
glutathione peroxidase removal 
(GPX4 or PHGPX) 
5 Thyroid hormone deiodinase 1 (D1) Conversion ofT4 to T3 Thyroid gland, liver, kidney, h lp32-p33 
Inactivation of T3 and T4 central nervous system 
6 Thyroid hormone deiodinase 2 (D2) Conversion ofT4 to T3 Pituitary and thyroid glands, h 14q24.3 
placenta, heart and skeletal muscles, 
central nervous system, brown fat 
7 Thyroid hormone deiodinase 3 (D3) Inactivation of T3 and T4 Placenta, central nervous system, skin h 14q32 
m 12F1 
8 Thioredoxin reductase (TR1) NADPH-dependent Ubiquitous h 12q23-q24.1 
reduction of thioredoxin 
9 Selenophosphate synthetase 2 (SPS2) Synthesis of selenophosphate Ubiquitous m chr. 7 
10 Selenoprotein P (SelP) Antioxidant? Plasma h 5q31 
Selenium storage? 
11 Selenoprotein W (SelW) Redox? Ubiquitous h 19q 13.3 
12 15-kd selenoprotein Protein folding? Ubiquitous h 1 p31 
Chromosomal localization is shown for human (h) and mouse (m) selenoprotein genes. 
mice lacking the GPX I gene were generated, no pheno- 
typic changes were observed in these knockout mice, even 
under hyperoxia conditions [54]. However, recent find- 
ings of the essential role of GPX1 in protection of mice 
from viral-induced myocarditis suggest that this enzyme 
may be important in rescuing cells from environmental 
stress [4], while its function under normal conditions may 
be compensated forby other cellular components. 
Supplementation f the diet with selenium has been 
shown to reduce the risk of prostate, colon and lung can- 
cers [23], and chemopreventive properties of this element 
have been associated with GPX1. Expression of this 
enzyme is often altered in malignant cells relative to con- 
trois [30]. Interestingly, GPX1 exhibits contrasting pat- 
terns of regulation with another antioxidant selenoen- 
zyme, thioredoxin reductase, in several tested cancer sys- 
tems [41]. Further research is necessary to determine 
which selenoprotein(s) are indeed responsible for chemo- 
preventive properties of selenium. 
(2) Glutathione Peroxidase 2 (GPX2 or GPX-GI). 
GPX2, like GPX1, is a tetramer consisting of identical 
22-kd subunits and occurs in the cytosol. However, in 
contrast to GPX1, which is expressed in every cell type 
tested, GPX2 is mainly expressed in the epithelium of the 
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gastrointestinal tract [22]. In this organ, GPX2 activity 
accounts for about 50% of the total selenium-dependent 
glutathione peroxidase activity [31 ]. 
(3) Glutathione Peroxidase 3 (GPX3 or pGPX). PX3 
differs from other glutathione peroxidases in that it is a 
glycoprotein and it is the only extracellular selenium-con- 
taining glutathione peroxidase. GPX3 is able to detoxify 
hydroperoxides in the presence of glutathione. However, 
since the levels of glutathione in plasma are extremely 
low, an alternative reducing substrate has been sought. 
Indeed, it was found that thioredoxin, thioredoxin reduc- 
tase or glutaredoxin are better electron donors than gluta- 
thione for GPX3 under physiological conditions [tl]. 
These findings are reinforced by the lack of conservation 
of the glutathione-binding site in this glutathione peroxi- 
dase [94]. The crystal structure at 2.9 A has been recently 
reported for GPX3 [81] providing an explanation for dif- 
ferences in substrate specificity and catalytic activities of 
plasma nd intracellular glutathione peroxidases. 
(4) Glutathione Peroxidase 4 (GPX4 or PHGPX). 
GPX4 is different from other selenium-dependent glu a- 
thione peroxidases in that it is capable of reducing phos- 
pholipid hydroperoxides. GPX4 is an - 19-kd monomer- 
ic enzyme and it occurs in both a soluble and a mem- 
brane-bound form. The subcellular localization of GPX4 
is controlled by alternative transcription and translation 
sites [78]. Under conditions of limiting selenium, seleni- 
um is preferentially incorporated into GPX4 relative to 
GPX1. GPX4 is ubiquitously expressed and is one of the 
most abundant selenoproteins in mammals (the other 
most abundant intracellular selenoproteins are GPX1, 
thioredoxin reductase (TR) and the 15-kd selenoprotein). 
The dramatic elevation of GPX4 expression i testis after 
puberty suggests hat this selenoenzyme ay have a role 
in the male reproductive system [69]. Other selenopro- 
teins may also be involved in mediating an essential role 
of selenium in spermatogenesis, particularly testis-spe- 
cific selenoproteins [87]. 
The Iodothyronine Deiodinase F mily 
The iodothyronine deiodinases are a family of three 
oxidoreductases that regulate the activity of thyroxine by 
catalyzing removal of iodine from the inner (5-iodine) or 
outer (Y-iodine) ring of this hormone. Thyroxine is 
secreted by the thyroid gland and the deiodinases, desig- 
nated type 1, type 2 and type 3 deiodinase or D 1, D2 and 
D3, are primarily located in mammalian tissues peripher- 
ally to the thyroid. Although D1, D2 and D3 have differ- 
ent roles in the activation and inactivation of thyroxine, 
these deiodinases share several common features. All 
three are selenoenzymes containing the Sec residue in a
highly homologous sequence that is located in the midre- 
gion of each protein. Sec occurs at the enzymes' active 
center and is most likely involved in the transfer of iodine. 
Each deiodinase is an integral membrane protein and thus 
contains, as would be xpected, a hydrophobic sequence 
in the N-terminal portion of the enzyme. There are sever- 
aldistinct features of D1, D2 and D3 which are discussed 
below. It should also be noted that an excellent review on 
the deiodinase family has recently been published [62] 
and a more detailed account of the substrates, ubstrate 
specificities and primary structures of each deiodinase 
may be found in this review. 
(5) Type 1 Deiodinase (D1).  1 is a 29-kd selenopro- 
tein that iscapable of deiodinating both the inner and out- 
er ring of the prohormone, T4. Thus, D 1 can convert T4 to 
the active hormone, T3, as well as inactivate both T4 and 
T3. Its role is to provide T3 to the plasma nd to inactivate 
T4 and T3. It is located in the thyroid, liver, kidney and 
central nervous ystem and is a thyroid-responsive sele- 
noenzyme. 
D 1 occupies a unique historical position in the elucida- 
tion of selenoprotein biosynthesis in mammals. The loca- 
tion of the SECIS element in mammalian selenoprotein 
mRNA and the role of the SECIS element in determining 
that a UGA codon designates Sec instead of termination 
was first demonstrated with D1 mRNA [9, 10]. 
(6) Type 2 Deiodinase (D2).  is a 30.5-kd selenopro- 
tein that catalyzes the conversion of T4 to T3. The Km of 
D2 for T4 is three orders of magnitude lower than that of 
D 1 for T4. This selenoenzyme is essential for providing a
source of T3-receptor-bound T3 in the brain and pituitary 
gland. D2 activity may be regulated both pre- and post- 
translationally by T4 [see 24 and references therein]. 
Interestingly, a second TGA codon is encoded in the gene 
for rat and human D2 eight codons from the termination 
codon that may signal Sec insertion into protein or termi- 
nation of protein synthesis during transient expression 
[24, 85]. D2 is expressed inthe pituitary gland, the central 
nervous ystem, placenta nd brown fat of humans and 
rats and in the thyroid gland and skeletal and heart muscle 
of humans, but not rats. 
(7) Type 3 Deiodinase (D3).  is a 31.5-kd selenopro- 
tein that inactivates T3 and T4 by catalyzing the removal 
of iodine from the inner ring of either substrate. D3, like 
D 1, is a thyroid-responsive selenoenzyme and it plays the 
major role in inactivating T3 or T4. It occurs in placenta, 
the central nervous ystem and skin. D3 is expressed in
highest levels in placenta nd functions to impair access 
ofT3 and T4 to the fetus. 
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(8) Thioredoxin Reductase (TR) 
Mammalian TR was first characterized in late 1970s 
[56], but it was not until 1996 that this enzyme was recog- 
nized as a selenoprotein [38, 91]. Although most seleno- 
proteins contain Sec in the N-terminal portion or in the 
middle of the protein, TR contains Sec as a C-terminal 
penultimate r sidue [35, 38, 102], which is essential for 
enzyme activity [1, 42, 52]. TR is a homodimer consisting 
of two identical 55-kd subunits, each containing a ravin 
adenine dinucleotide cofactor. The major function of TR 
is to catalyze NADPH-dependent reduction of thioredox- 
in in the cytosol [83]. In addition, TR has been implicated 
in a variety of processes, including the reductions ofgluta- 
thione peroxidase [11], disulfide isomerase (and related 
enzymes) [67, 68], dehydroascorbate [73], ascorbyl-free 
radical [74], selenite, selenodiglutathione [13], hydro- 
peroxides [12] and other proteins and compounds. The 
broad substrate specificity of TR has been attributed to 
the presence of Sec in the enzyme. However, the puzzling 
location of Sec in a conserved C-terminal Gly-Cys-Sec- 
Gly tetrapeptide cannot be explained easily, since other 
members of the pyridine nucleotide-disulfide oxidoreduc- 
tase family, such as glutathione r ductase and lipoamide 
dehydrogenase, lack the C-terminal See-containing exten- 
sion [38]. Relative to these other enzymes, TR has three 
orders of magnitude higher eactivity to several inhibitory 
gold, quinone and alkylating compounds [1, 28, 44, 60, 
71, 72, 76, 95]. The high reactivity of TR to these com- 
pounds has also been attributed to Sec in the enzyme. The 
purified reduced TR can be inactivated by oxygen, while 
elevated levels of oxygen in the growth medium resulted 
in a lower specific activity of TR. These oxygen-depen- 
dent processes have been associated with the loss of sele- 
nium from the enzyme [42]. 
TR is often overexpressed in malignant tissues [34, 38, 
41] and it has oncoprotein-like properties [59]. Products 
of oncogenes may stimulate cell proliferation and also 
sensitize cells to apoptosis [32]. A role of TR and its sub- 
strate thioredoxin i  cell proliferation [3, 33, 34, 90] and 
apoptosis [25, 55, 84] has been reported. In addition, TR 
and thioredoxin are involved in redox regulation f cell 
signaling [87]. TR occurs in a variety of isoform and 
isoenzyme types [38, 42, 61, 82, 87, 91]. We recently dis- 
covered and characterized two new mammalian thiore- 
doxin reductases TR2 and TR3 that contain a TGA- 
encoded Sec residue [87]. TR2 is preferentially expressed 
in testis, while TR3 contains a mitochondrial targeting 
signal and is expressed invarious cell types [87]. 
(9) Selenophosphate Synthetase 2 (SPS2) 
SPS2 is a recently discovered -50-kd selenoenzyme 
[45]. It catalyzes activation of selenium in an ATP-depen- 
dent manner. The product, which is selenophosphate, 
donates elenium to the intermediate in the biosynthesis 
of Sec on tRNA. The natural selenoenzyme has not been 
isolated, which precluded its detailed characterization, 
but the selenide-dependent ac ivity has been demon- 
strated for the overexpressed cysteine-for-Sec mutant of 
SPS2 [58]. SPS2 is homologous to mammalian seleno- 
phosphate synthetase 1 (SPS1), with the latter replacing 
the putative active center Sec with threonine [65]. Which 
of these two selenophosphate synthetases is the major pro- 
tein involved in selenoprotein synthesis remains to be 
determined. Selenophosphate synthetase g nes have been 
found in bacteria, archaea, Drosophila melanogaster and 
Caenorhabditis elegans. These gen s encode ither Sec- 
containing or homologous cysteine-containing enzymes. 
The finding of Sec in mammalian SPS2 is important in 
view of the possible autoregulation mechanism ofseleno- 
protein synthesis, i.e., SPS2 is possibly involved in its own 
biosynthesis [45]. 
(10) Selenoprotein P (Sel P) 
Sel P (P designates plasma) is a 57-kd glycoprotein and 
is the major selenoprotein in the plasma of mammals [51]. 
It contains 9-12 Sec residues depending on the organism 
in which it occurs and is the only known selenoprotein 
that contains more than one Sec residue [80]. All Sec resi- 
dues in this selenoprotein are coded by UGA. The effi- 
ciency of Sec incorporation ateach UGA codon in Sel P 
mRNA appears to be different which results in multiple 
product forms [21] that arise from termination at differ- 
ent UGA codons [53]. In particular, the second in-frame 
UGA codon dictates ignificant termination giving rise to 
a selenoprotein product that may have a separate function 
[53]. Sel P contains two types of SECIS elements in the 
3'-untranslated region of its mRNA suggesting that both 
are required for Sec insertion in response to multiple and 
different UGA codons [50]. The protein is rapidly ex- 
pressed following supplementation of selenium-deficient 
animals with selenium. It has been suggested that Sel P 
serves as an antioxidant [ 17] or selenium storage (or trans- 
port) protein. Further studies are required to establish the 
function of this interesting selenoprotein. 
(I 1) Selenoprotein W (SelW) 
SelW is a -8-kd intracellular protein of unknown 
function [96]. A single Sec residue is present in this pro- 
tein in an N-terminal putative active center edox motif 
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Cys-Gly-Ala-Sec-Gly [97], suggesting the possible in- 
volvement of the protein in a redox-related process. The 
isolated protein may occur in the glutathionylated form 
[8], which is consistent with a putative redox role for 
SelW. The protein is expressed in many tissues and in 
increased levels in muscle and brain. SelW expression, as 
well as expression of most other selenoproteins are regu- 
lated by selenium [ 101 ], i.e., selenium elevates selenopro- 
tein expression. 
(12) 15-kd Selenoprotein 
The 15-kd protein is the most recently discovered sele- 
noprotein. It contains asingle Sec residue in the middle of 
the protein in a conserved Cys-Gly-Sec-Lys putative re- 
dox-active center [39]. The 15-kd protein does not share 
any sequence homology to previously characterized pro- 
teins and its function currently is not known. The 15-kd 
selenoprotein s expressed in a variety of tissues with 
increased levels in prostate and thyroid. It has been found 
in humans, mice and rats. C. elegans and Brugia malayi 
also contain homologs of this selenoprotein, but the ho- 
mologs have cysteine in place of Sec. 
Preliminary evidence suggests that the 15-kd seleno- 
protein may be involved in cancer [40]. Indeed, seleno- 
protein expression is altered in several tested cancers and 
two cancer-related polymorphisms have been found in the 
3'-untranslated region of the human protein, including 
one in the SECIS element. These variations in sequence 
may potentially affect he expression level of the protein 
in malignant relative to normal tissue. 
The 15-kd protein has been isolated from rat prostate 
and mouse liver in a complex with UDP-glucose glyco- 
protein glucosyltransferase (UGTR) [40]. Interestingly, 
UGTR is involved in quality control of protein folding by 
glucosylating misfolded proteins and directing them for 
degradation. If indeed the 15-kd protein is involved in 
this process, it will be an interesting new role for a seleno- 
protein. 
The Future: Role of Sec in Health and Total 
Number of Selenoproteins 
The role that selenium plays as an important compo- 
nent in the diet of mammals apparently changes with age. 
That is, selenium serves as an absolutely essential micro- 
nutrient in early mammalian development since removal 
of the Sec tRNA gene from the mouse genome is lethal to 
the embryo [15]. Furthermore, rats that are weaned at 
birth onto a selenium-deficient diet manifest dramatically 
slower rates of growth, abnormal muscle and skeletal 
development, develop cataracts and a variety of other dis- 
orders as compared to their siblings maintained on a sele- 
nium-sufficient diet. Adult rats and mice maintained on a 
selenium-deficient diet for extended periods of time ap- 
pear to be less affected by the loss of selenium unless chal- 
lenged by environmental stress. Although in studies in- 
volving selenium-deficient a imals, selenoprotein expres- 
sion has not been reduced as effectively as in Sec tRNA 
gene knockout studies, these nutritional experiments sug- 
gest that the role of selenium may change from an essen- 
tial requirement to sustain life in embryonic development 
to one that is a requirement for adequate growth and 
development a birth to more of a chemopreventive or 
protective agent against environmental stress in later life. 
Studies involving conditional removal of the Sec tRNA 
gene from the genome of mice (i.e., conditional knock- 
outs) at selected stages of development and in selected tis- 
sues [5, 77, 79] should provide further insight into defin- 
ing the role of selenium throughout life. Experiments in
which mice are generated carrying the Sec tRNA gene so 
that the gene can be conditionally removed from the 
genome of mice are in progress [Hatfield, unpubl, data]. 
Selenium deficiency in humans is associated with nu- 
merous health disorders, including increased cancer isk, 
AIDS mortality, heart disease and problems with the male 
reproductive system [23, 63, 69]. This may be explained 
by the fact that selenium deficiency results in decreased 
selenoprotein expression and, hence, in the disruption of 
processes that are maintained by these selenoproteins. 
Supplementation f the human diet with selenium there- 
fore offers a potentially efficient and inexpensive means 
of preventing or delaying the onset of certain of these mal- 
adies. Future research will, no doubt, result in determin- 
ing the precise mechanisms of how selenium benefits 
human health and in offering this micronutrient as a 
dietary supplement topeople at risk of developing various 
types of cancer, AIDS and other diseases that are in- 
fluenced by selenium. Most certainly, many, if not all, of 
the beneficial effects of selenium on human health are 
mediated by selenoproteins, but which selenoproteins are 
involved and their role is not well understood. It is also 
quite likely that many protective ffects of selenium are 
mediated by yet-to-be characterized selenoproteins. 
The total number of selenoproteins that are encoded in 
the genomes of mammals is difficult to predict. Various 
estimates range from 25 to 100. These estimates are based 
on 75Se-labeling experiments, which detect selenoprotein 
spots on 2D gels [6, 7], and on the extrapolation of the 
current proportion of known selenoproteins among all 
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characterized proteins taking into account that many sele- 
noproteins are expressed in low levels [Gladyshev, un- 
publ. data]. In fact, the growing interest in discovering 
novel selenoproteins is hampered in part by the difficul- 
ty involved in their identification due to low expression 
levels. 
An important task in further developing the selenopro- 
tein field and in elucidating the role of selenium in human 
health is the detection, isolation and characterization f 
additional selenoproteins. There are several approaches 
that may be used in identifying new selenoproteins. For 
example, isolation of labeled proteins from tissues and 
cells following labeling of animals and cell lines with 75Se. 
Historically, this has been the most productive approach 
in identifying new selenoproteins and it still proves to be a 
useful technique for this purpose. More recently, identifi- 
cation of Sec-encoded TGA codons and of SECIS ele- 
ments followed by determination of the selenoprotein 
open reading frame in nucleotide databases has been very 
useful in finding novel selenoproteins. Searches of data- 
bases utilizing the unique features of the Sec insertion 
machinery have been aided tremendously b recent de- 
velopments in projects involving sequencing of entire 
genomes, and by the expressed sequence tag projects. For 
example, the approach of identifying SECIS elements in 
nucleotide databases was recently applied to search for 
potential SECIS elements in the HIV genome [43, 92]. 
SECIS elements are characterized by the presence of a 
highly conserved ATGAN[ 10-12 nucleotides]AAN[ 16- 
26 nucleotides]NGAN sequence, which forms stem-loop 
structures with AAN located in the loop, and TGAN and 
NGAN forming the non-Watson-Crick quartet interac- 
tion [66, 99]. Searching for SECIS elements in nucleotide 
databases is a unique tool for identifying new mammalian 
selenoproteins [Kryukov and Gladyshev, unpubl, data]. 
An alternative computer approach to search for novel 
selenoproteins i volves an examination ofnucleotide da- 
tabases for Sec TGA codons. This approach takes advan- 
tage of the fact that many mammalian selenoproteins 
have homologs in lower eukaryotes, and these homologs 
incorporate cysteine in place of Sec. Thus, computer 
approaches may be utilized that search for in-frame TGA 
codons in the mammalian nucleotide sequences that cor- 
respond to TGC/T in lower organisms. 
The above approaches of 'digital cloning' for discover- 
ing new selenoproteins are unlikely to result in the identi- 
fication of all mammalian selenoprotein genes, but the 
development of these methods will be useful for future 
whole genome sequence analyses. Completion of the se- 
quence of the human genome, which is scheduled to be 
finished in 2003 [100], as well as completion of the C. ele- 
gans and D. melanogaster genome projects will be invalu- 
able in detecting all selenoprotein genes encoded in these 
genomes. 
An additional area to be explored in the near future is 
high-throughput, comprehensive analysis of relative 
transcript expression levels [104]. The emerging techno- 
logies, such as serial analysis of gene expression, differ- 
ential display pproaches and various hybridization anal- 
yses (such as microchips and membranes) will not only 
reveal parallel changes in selenoprotein expression, but 
also determine how selenium affects expression of pro- 
teins that do not contain selenium. 
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